1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Characteristics of the development and validation cohortsa
Development (n = 409)Validation (n = 317)P Value
Age (mean) (SD) (yr)57 (13)59 (14).05
Female sex277 (68)222 (70).5
History of hypertension131 (35)96 (31).2
History of cardiovascular disease75 (20)61 (20)1
History of diabetes25 (7)18 (6).6
WFNS score.04
 I182 (46)106 (39)
 II51 (13)37 (14)
 III12 (3)9 (3)
 IV68 (17)40 (15)
 V81 (21)74 (27)
Aneurysm location.44
 Anterior circulation324 (79)243 (82)
 Posterior circulation85 (21)54 (18)
Aneurysm size (median) (IQR) (mm)6 (4–9)5 (4–8).96
Aneurysm treatment<.001
 Coiling273 (67)153 (48)
 Clipping64 (16)95 (30)
 No treatment72 (18)69 (22)
Total blood volume (median) (IQR) (mL)29 (12–60)26 (9–51).36
Cisternal blood volume (median) (IQR) (mL)20 (8–41)18 (6–34).1
Intraventricular blood volume (median) (IQR) (mL)0.5 (0–2)0.3 (0–2).1
Intraparenchymal blood volume (median) (IQR) (mL)0 (0–3)0 (0–3).8
Modified Fisher grade.15
 020 (5)12 (4)
 126 (6)9 (3)
 27 (2)8(3)
 392 (23)83 (27)
 4262 (64)201 (64)
Clinical DCI109 (27)61 (29).6
  • Note:—DCI indicates delayed cerebral ischemia.
  • ↵a All values are in No. (%) unless otherwise indicated.